cilastatin--imipenem-drug-combination and Pleural-Effusion

cilastatin--imipenem-drug-combination has been researched along with Pleural-Effusion* in 1 studies

Other Studies

1 other study(ies) available for cilastatin--imipenem-drug-combination and Pleural-Effusion

ArticleYear
A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection.
    BMC infectious diseases, 2019, Aug-15, Volume: 19, Issue:1

    Non-tuberculous mycobacteria cause chronic pulmonary infection, but pleuritis and pleural effusion are rarely associated with infection with non-tuberculous mycobacteria, especially rapid-growing mycobacteria.. A 68-year-old woman with rheumatoid arthritis who was using prednisone, azathioprine, and certolizumab pegol presented complaining of fever, dry cough, and night sweats for the past 2 weeks. Chest examination revealed bilateral opacity that was more pronounced on her right side. Bronchoalveolar lavage fluid and pleural effusion fluid were obtained, and revealed coinfection with Mycobacterium fortuitum and Mycobacterium mageritense. Imipenem/cilastatin, levofloxacin, and minocycline were prescribed for 6 months, and the patient was well and asymptomatic for the subsequent 6 months.. This is the first case report describing pleural effusion associated with coinfection with two different mycobacterial species. If the species cannot be identified, the possibility of mycobacterial coinfection should be considered.

    Topics: Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cilastatin, Imipenem Drug Combination; Coinfection; Female; Humans; Levofloxacin; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pleural Effusion

2019